CSI’s team Day 2

Mid-term Report



Problem-Solution Fit


  • easy to copy packaging
  • sell products that contain no active ingredient
  • Non-existent Traceability
  • Unknown and unchecked expiration date
  • Paper intensive process, creates overhead
  • Doctors are doing logistics work
  • No information available at all levels of decision making
  • systems are not integrated
  • User cannot identify a fake drug/vaccine
  • Admin processes are slow and error prone
  • no clear borders to determine areas of responsibility
  • light penalties for counterfeiting drugs/vaccines
  • no unify system of packaging
  • no regulation that requires consistent validation from governments
  • regional differences and lack of global approach
  • lack of awareness and education of the ‘unsafe’ chain
  • higher demand and supply
  • development of unreliable alternative channels (online)
  • corruption and lack of compliance


  • uniquely identifiable and traceable vaccine/drug
  • only accredited producers can introduce vaccines/drugs
  • QR code can capture important information and can provide the means to identify gaps
  • trace trajectory at each point
  • processes can be digitized, automate and simplified
  • open access database
  • system system, open API that enables access to the public information
  • user can be empowered to validate authenticity of the drug/vaccine (embedded in the QR code)
  • decision makers can have access to data that allows for informed decisions and possibly regulations
  • packaging agnostic
  • unified and universal visibility that minimizes regional differences
  • Possibility to be informed and have access to safety tips that can be validated by the health providers
  • Identify gaps in stock and provides visibility of demand and waste (expired vials)
  • Visibility and transparency of the supply chain can diminish corrupt behavior and self-interest